The relationship between faecal toxin titre, histological evidence of pseudomembrane in the rectum, and severity of antibiotic-associated colitis has been analysed from data on 62 patients whose faeces contained Clostridium difficile toxin. There was a significant correlation between a toxin titre of 6400 or more and the presence of pseudomembrane (p < 0 05). There was no correlation between toxin titre, duration of diarrhoea, total white cell count, temperature, serum albumin or serum orosomucoid concentrations. There was, however, a significant correlation between the presence of rectal pseudomembrane and duration of diarrhoea (p < 0-005). Exposure to clindamycin or lincomycin was also associated with a significantly higher toxin titre than that seen in patients who were given other antibiotics. The duration of diarrhoea was not longer and rectal pseudomembrane did not occur more often in the patients who had received clindamycin or lincomycin.
SUMMARY
The relationship between faecal toxin titre, histological evidence of pseudomembrane in the rectum, and severity of antibiotic-associated colitis has been analysed from data on 62 patients whose faeces contained Clostridium difficile toxin. There was a significant correlation between a toxin titre of 6400 or more and the presence of pseudomembrane (p < 0 05). There was no correlation between toxin titre, duration of diarrhoea, total white cell count, temperature, serum albumin or serum orosomucoid concentrations. There was, however, a significant correlation between the presence of rectal pseudomembrane and duration of diarrhoea (p < 0-005). Exposure to clindamycin or lincomycin was also associated with a significantly higher toxin titre than that seen in patients who were given other antibiotics. The duration of diarrhoea was not longer and rectal pseudomembrane did not occur more often in the patients who had received clindamycin or lincomycin.
Clostridium difficile has been implicated as the aetiological agent responsible for antibiotic-associated pseudomembranous colitis (AAC 
Results
The titres of faecal toxin varied from 50 to 640 000 in the 62 patients, and showed a normal distribution. There were 26 patients with a titre greater than 6400, 28 with a titre less than 6400, and 8 with a titre of 6400. The relation between the faecal toxin titre and the presence or absence of histologically confirmed rectal pseudomembrane in the 28 patients in whom these investigations were done within the same 24-hour period is shown in the Fig. In In 32 patients, faecal toxin was identified after clindamycin or lincomycin treatment. The toxin titre in these patients was compared with that in 30 patients who had received other antibiotics before faecal toxin was identified (Table 3) . A high toxin titre was present significantly more often in patients who had received clindamycin or lincomycin than in patients whose illness followed other antibiotics (X2 with Yates correction = 49, p < 0-05). Comparison of the logio titres in the two groups of patients also showed a significant difference (t = 2-672, p < 0-01). There was no significant increase in the incidence of rectal pseudomembrane or in duration of diarrhoea in patients who had received clindamycin or lincomycin treatment (Table 3) . 
Discussion
Sigmoidoscopy and rectal biopsy in patients with florid diarrhoea due to AAC may be technically difficult, and their diagnostic value is limited because the rectum is not affected by pseudomembrane in some patients. In contrast, the test for Cl difficile toxin in faeces is easily performed, and provides reliable diagnostic data. Measurement of the titre of faecal toxin is also relatively simple. It would be convenient if the level of the titre gave an indication of the severity of the disease, and assisted prognosis. Although there was a statistically significant correlation between a high toxin titre and the presence of pseudomembrane, this correlation was imperfect when judged in individual patients. It is necessary therefore to decide which of these two potential indices of disease severity is more reliable. Prolonged diarrhoea is the most characteristic of the various clinical and laboratory findings in patients with AAC, and is therefore a potentially useful indicator of disease severity. The correlation between the presence of rectal pseudomembrane and an increased duration of diarrhoea suggests that identification of pseudomembrane may be of value in determining the prognosis. In contrast, the absence of any correlation between the toxin titre and duration of diarrhoea is not unexpected, because the latter is likely to be determined by the length of time in which toxin-producing Cl difficile inhabit the intestine.
Leucocytosis, pyrexia, hypoalbuminaemia, and raised serum orosomucoid concentrations have all been described in patients with AAC.8 The absence of any statistically significant difference in these parameters between patients with high or low toxin titres, or in the presence or absence of rectal pseudomembrane raises the possibility that the changes observed may be more closely related to other underlying disorders than to AAC. Conversely, any real changes in these measurements arising from AAC may have been masked by the effect of the underlying disease. Many of the patients studied had had surgery, often for malignant disease, and some cases were complicated by wound infection. Therefore the part played by AAC in causing the observed changes in white cell count, temperature, and albumin and orosomucoid concentrations is not clear.
Perhaps the most intriguing finding was the significant relation between exposure to clindamycin or lincomycin and a high faecal toxin titre. This comparison was made because in vitro experiments have shown that Cl difficile produces the most toxin when grown in the presence of clindamycin or lincomycin.9 Toxin production was not enhanced by penicillins, cephalosporins, aminoglycosides, tetracycline, vancomycin, or bacitracin. At first sight this finding would support the widely-held belief that clindamycin and lincomycin predispose to a more severe form of AAC than other antibiotics. However, the incidence of rectal pseudomembrane was not significantly greater in the clindamycin-or lincomycin-treated patients. We believe that the amount of toxin measurable in faeces is not the major determinant for the formation of pseudomembrane. The duration of exposure to Cl difficile toxin may be the primary factor in determining the outcome, and production of toxin by clostridia adhering to the mucosa may also be important.
We conclude that the detection in faeces of the toxin produced by Cl difficile is a useful method for the diagnosis of AAC, but that determination of the toxin titre does not provide additional useful information. Histological evidence of pseudomembrane in a rectal biopsy is of value in identifying those patients with extensive pseudomembranous changes, and with a more serious prognosis. 
